our track record
2006
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2006
biosurfit wins ANJE (Associação Nacional de Jovens Empresários) entrepreneur of the year
2009
biosurfit receives ISO9001: 2008 & ISO13485:2004 certification from TÜV Rheinland
2010
biosurfit wins “Hospital do Futuro” award
2010
biosurfit receives the results of the “Point of care medical test market research”, project delivered by IMS Healthcare
2011
biosurfit wins the “Growth Companies Competition” in the HiTBarcelona -World Innovation Summit.
2012
Semi-automated production line validated
2012
biosurfit gets CE Marking of the spinit® instrument and the first test, spinit® CRP for quantitative measurement of C-Reactive Protein in blood
2013
biosurfit wins Start-up of the Year award from Portugal Ventures
2013
biosurfit was present at MEDICA, the world’s largest Medicine Forum, for the first time as an exhibitor
2013
June: first distribution agreement signed with Rev Diagnostics, The Netherlands
2013
Awarded €1.4m grant by the European Commission’s 7th Framework Programme
2014
May: biosurfit receives CE Mark for spinit® Blood Count test
2014
February: biosurfit’ s first commercial sale in the Netherlands
2015
biosurfit secures €12 million loan from the European Investment Bank
2015
biosurfit wins “Live Sciences & Med Tech Venture of the Year” from Portugal Ventures
2015
biosurfit secures €4.3 of public funding from the European Union program PT2020
2016
biosurfit receives CE mark for the spinit® HbA1c test
2016
Several distribution contracts signed in Europe
2016
spinit® launched in 13 different countries
2017
IFCC and NGSP certification for spinit® HbA1c
2017
biosurfit wins award of distinction “BORN FROM KNOWLEDGE” at the 14th National Meeting of Innovation COTEC-ANI
2017
new manufacturing facility in Azambuja
2017
biosurfit achieves a significant commercial milestone - 500 spinit® Instruments placed with European Customers
2018
New website launch
2018
biosurfit receives Innovation Award at the first edition of the EIB Venture Debt Summit
2018
biosurfit signs strategic Partnership - €10 million of equity financing from Boule Diagnostics and 200M co-investment fund
2019
biosurfit launches new sample collection method | spinit® strip
2019
Launch of spinit® CRP and spinit® HbA1c controls solution.
2020
smart triage in partnership with the Red Cross
2020
Opening of the first Smart Triage mobile unit in Azambuja
Opening of a mobile unit in Telheiras, Corroios and Cascais
2020
Development of the COVID Checked brand for testing solutions in mobile units
2021
biosurfit receives CE mark for the spinit® COVID-19 test